<DOC>
	<DOCNO>NCT00328575</DOCNO>
	<brief_summary>The purpose study determine use intensity modulate radiation therapy brain metastasis safe improve local control standard whole brain radiation therapy .</brief_summary>
	<brief_title>Using Intensity Modulated Radiation Therapy ( IMRT ) Brain Metastases</brief_title>
	<detailed_description>Traditionally , whole brain radiation therapy ( WBRT ) primary therapy patient brain metastasis . Despite therapy , patient still poor survival four six month . Untreated patient median survival one month . Up one half patient die cause related presence brain metastasis . In Phase I/II RTOG trial , efficacy safety deliver accelerated fractionation investigate patient good prognostic factor . No toxicity observe escalate dose irradiation 70.40Gy 1.6Gy twice daily treatment . However , randomized trial , use hyperfractionation appear improve survival compare 30Gy whole brain irradiation deliver 10 fraction . Current therapeutic approach also include stereotactic radiosurgery ( SRS ) . Several retrospective study demonstrate improved local tumor control 80 % addition SRS WBRT . These local control rate comparable surgery . In recently publish randomized trial RTOG 95-08 ( TJU accrue 42 patient trial ) , Andrews et al . demonstrate improved survival patient solitary brain lesion treat SRS . Median survival 6.5 month patient treat WBRT SRS compare 4.9 month patient treat WBRT alone . Also , patient likely stable improve performance status .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>Histologically confirm malignancy 25 parenchymal brain metastasis magnetic resonance imaging ( MRI ) maximum size 4 cm Partial resection allow . Complete resection allow patient 3 lesion . Karnofsky Performance Status ( KPS ) equal great 60 Neurologic function equal great 2 Recurrent brain tumor Major medical psychiatric illness Metastases brainstem , midbrain , pons , medulla Patients leukemia lymphoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Brain metastasis</keyword>
	<keyword>Parenchymal</keyword>
	<keyword>Neoplasm</keyword>
	<keyword>IMRT</keyword>
	<keyword>Intensity Modulated Radiation Therapy</keyword>
</DOC>